JPS635040B2 - - Google Patents
Info
- Publication number
- JPS635040B2 JPS635040B2 JP57123913A JP12391382A JPS635040B2 JP S635040 B2 JPS635040 B2 JP S635040B2 JP 57123913 A JP57123913 A JP 57123913A JP 12391382 A JP12391382 A JP 12391382A JP S635040 B2 JPS635040 B2 JP S635040B2
- Authority
- JP
- Japan
- Prior art keywords
- tetraisopropyldisiloxane
- diyl
- adenine
- arabinofuranosyl
- adenosine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims description 36
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims description 18
- 229960005305 adenosine Drugs 0.000 claims description 18
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims description 13
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 12
- 229930024421 Adenine Natural products 0.000 claims description 12
- OIRDTQYFTABQOQ-UHTZMRCNSA-N Vidarabine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O OIRDTQYFTABQOQ-UHTZMRCNSA-N 0.000 claims description 12
- 229960000643 adenine Drugs 0.000 claims description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 125000006239 protecting group Chemical group 0.000 claims description 4
- 239000011541 reaction mixture Substances 0.000 claims description 4
- 125000003317 D-arabinofuranosyl group Chemical group [H]OC([H])([H])[C@@]1([H])OC([H])(*)[C@@]([H])(O[H])[C@]1([H])O[H] 0.000 claims description 2
- 238000003795 desorption Methods 0.000 claims description 2
- 238000004064 recycling Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 description 21
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 238000000746 purification Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 239000007858 starting material Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 4
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- -1 mercaptopurine nucleoside Chemical class 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- UQOKRDJILZMZKU-UHFFFAOYSA-N 2-nitropyrimidine Chemical compound [O-][N+](=O)C1=NC=CC=N1 UQOKRDJILZMZKU-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 229930194542 Keto Natural products 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 241000700584 Simplexvirus Species 0.000 description 2
- 241000700618 Vaccinia virus Species 0.000 description 2
- RANSNKOSWWZYEJ-XJCFNFQFSA-N [(1s,2r,4r,5s)-2-(6-aminopurin-9-yl)-3,6-dioxabicyclo[3.1.0]hexan-4-yl]methanol Chemical compound NC1=NC=NC2=C1N=CN2[C@H]1[C@H]2O[C@H]2[C@@H](CO)O1 RANSNKOSWWZYEJ-XJCFNFQFSA-N 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 125000000089 arabinosyl group Chemical class C1([C@@H](O)[C@H](O)[C@H](O)CO1)* 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 125000000468 ketone group Chemical group 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- FCZOVUJWOBSMSS-UHFFFAOYSA-N 5-[(6-aminopurin-9-yl)methyl]-5-methyl-3-methylideneoxolan-2-one Chemical compound C1=NC2=C(N)N=CN=C2N1CC1(C)CC(=C)C(=O)O1 FCZOVUJWOBSMSS-UHFFFAOYSA-N 0.000 description 1
- 208000000903 Herpes simplex encephalitis Diseases 0.000 description 1
- 208000037018 Herpes simplex virus encephalitis Diseases 0.000 description 1
- 208000005100 Herpetic Keratitis Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 206010073938 Ophthalmic herpes simplex Diseases 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- GSKVLVXXJRJNAN-UHFFFAOYSA-N [di(propan-2-yl)-$l^{3}-silanyl]oxy-di(propan-2-yl)silicon Chemical compound CC(C)[Si](C(C)C)O[Si](C(C)C)C(C)C GSKVLVXXJRJNAN-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 125000000328 arabinofuranosyl group Chemical group C1([C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- DDYAZDRFUVZBMM-UHFFFAOYSA-N chloro-[chloro-di(propan-2-yl)silyl]oxy-di(propan-2-yl)silane Chemical compound CC(C)[Si](Cl)(C(C)C)O[Si](Cl)(C(C)C)C(C)C DDYAZDRFUVZBMM-UHFFFAOYSA-N 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006477 desulfuration reaction Methods 0.000 description 1
- 230000023556 desulfurization Effects 0.000 description 1
- 230000003009 desulfurizing effect Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000010436 fluorite Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 201000010884 herpes simplex virus keratitis Diseases 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229960001428 mercaptopurine Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Saccharide Compounds (AREA)
Description
【発明の詳細な説明】
本発明は、高純度の9―(β―D―アラビノフ
ラノシル)アデニンを高収率で製造する新規な方
法に関するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel method for producing highly pure 9-(β-D-arabinofuranosyl)adenine in high yield.
9―(β―D―アラビノフラノシル)アデニン
(以下アラビノフラノシルアデニンと略す)は、
ヘルペス・シンプレツクス・ウイルス(Herpes
Simplex Virus)、バキニア・ウイルス
(Vaccinia Virus)などに対する抗ウイルス性作
用を有する化合物であり、ヘルペス性の角膜炎及
び脳炎の治療薬として用いられている。 9-(β-D-arabinofuranosyl)adenine (hereinafter abbreviated as arabinofuranosyl adenine) is
Herpes simplex virus (Herpes)
It is a compound that has antiviral effects against Vaccinia Virus (Simplex Virus) and Vaccinia Virus, and is used as a treatment for herpetic keratitis and encephalitis.
これまで、アラビノフラノシルアデニンの製法
としては、2′,3′―エポキシアデノシンを製造
し、これを開環反応させる方法(J.Am.Chem.
Soc.第82巻、第2648ページ)、置換アラビノース
とアデニン誘導体とを直接縮合させる方法(J.
Org.Chem.、第28巻、第3004ページ)、アラビノ
フラノチオキサゾリジンとニトロピリミジンとを
縮合させ、これを還元後還化してメルカプトプリ
ンヌクレオシドとし、これを脱硫する方法(米国
特許第3948883号明細書)、8,2′―型プリンシク
ロヌクレオシドを開裂させる方法(特公昭47−
7271号公報、特開昭48−14694号公報)、3′,5′―
O―アシルアデノシン誘導体を酸化してケト誘導
体に変え、次いで還元する方法(特開昭54−
73795号公報)などが提案されている。 Until now, the method for producing arabinofuranosyladenine has been to produce 2',3'-epoxyadenosine and subject it to a ring-opening reaction (J.Am.Chem.
Soc. Vol. 82, p. 2648), Direct condensation of substituted arabinose and adenine derivatives (J.
Org.Chem., Volume 28, Page 3004), a method of condensing arabinofuranothioxazolidine and nitropyrimidine, reducing and refluxing this to produce mercaptopurine nucleoside, and desulfurizing this (US Pat. No. 3,948,883). Specification), Method for cleaving 8,2'-type purine cyclonucleosides (Specification)
7271, Japanese Patent Application Laid-open No. 14694), 3′, 5′-
A method of oxidizing O-acyladenosine derivatives to convert them into keto derivatives, and then reducing them (Japanese Patent Application Laid-open No. 1986-
73795) have been proposed.
しかしながら、2′,3′―エポキシアデノシンを
経る方法及び置換アラビノースとアデニン誘導体
とを反応させる方法は、多くの反応工程を要し、
また縮合反応に際し多くの副生物を伴うため、は
ん雑な精製処理を行わなければならない上に、収
率も低くなるのを免れないという欠点がある。ま
た、アラビノフラノチオキサゾリジンとニトロピ
リミジン誘導体とから出発する方法は、反応に長
時間を要する上に、縮合環化反応の操作も厄介で
あり、工業的製法として適当なものとはいえな
い。さらに8,2′―型プリンシクロヌクレオシド
を経る方法は、これの開裂反応を高温、高圧下で
長時間行わなければならず、また脱硫反応におい
てはラネーニツケルのような特殊の触媒を用いて
加熱する必要があるなど、装置やコストの面で問
題がある。最後に、3′,5′―O―アシルアデノシ
ンから出発する方法は、アシル体の分離、精製が
必要で、しかも、酸化生成物、還元生成物の精製
には、イオン交換樹脂カラムを用いることが不可
欠なため、生産効率の低下を免れないという欠点
がある。 However, the method via 2′,3′-epoxyadenosine and the method of reacting substituted arabinose with an adenine derivative require many reaction steps;
Furthermore, since many by-products are produced during the condensation reaction, complicated purification treatments are required and the yield is inevitably low. Furthermore, the method starting from arabinofuranothioxazolidine and a nitropyrimidine derivative requires a long time for the reaction and the operation of the condensation cyclization reaction is also troublesome, and cannot be said to be suitable as an industrial production method. Furthermore, in the method involving 8,2'-type purine cyclonucleoside, the cleavage reaction must be carried out at high temperature and pressure for a long time, and the desulfurization reaction requires heating using a special catalyst such as Raney nickel. There are problems in terms of equipment and cost. Finally, the method starting from 3',5'-O-acyladenosine requires separation and purification of the acyl form, and in addition, an ion exchange resin column must be used to purify the oxidation product and reduction product. Since this is essential, there is a drawback that production efficiency inevitably decreases.
このように、これまで知られているアラビノフ
ラノシルアデニンの製造方法は、いずれも工業的
に大量生産する方法としてはなんらかの欠点を有
し、必ずしも満足しうるものとはいえない。 As described above, all of the methods for producing arabinofuranosyladenine known so far have some drawbacks as a method for industrial mass production, and cannot be said to be necessarily satisfactory.
本発明者らは、このような従来方法のもつ欠点
を克服し、安価な原料から簡単な操作で、しかも
収率よく高純度のアラビノフラノシルアデニンを
製造するための工業的に行うのに適した方法を開
発すべく鋭意研究を重ねた結果、3′,5′―O―
(テトライソプロピルジシロキサン―1,3―ジ
イル)アデノシンを出発原料とし、これをジメチ
ルスルホキシドと無水酢酸とにより処理し、次い
でその反応生成物を還元すると、容易にアラビノ
フラノシルアデニンに変換しうる9―〔3′,5′―
O―(テトライソプロピルジシロキサン―1,3
―ジイル)―β―D―アラビノフラノシル〕アデ
ニンと出発原料である3′,5′―O―(テトライソ
プロピルジシロキサン―1,3―ジイル)アデノ
シンのみが生成し、しかもこの際には他の副生物
を伴わないので、特にイオン交換樹脂その他特別
の精製手段によるはん雑な精製を必要としないこ
とを見出し、この知見に基づいて本発明をなすに
至つた。 The present inventors have overcome the drawbacks of such conventional methods and have developed an industrial method for producing highly purified arabinofuranosyl adenine from inexpensive raw materials with simple operations and in good yield. As a result of intensive research to develop a suitable method, 3',5'-O-
(Tetraisopropyldisiloxane-1,3-diyl)adenosine is used as a starting material, treated with dimethyl sulfoxide and acetic anhydride, and then the reaction product is reduced, which can easily convert it to arabinofuranosyladenine. 9—[3′,5′—
O-(tetraisopropyldisiloxane-1,3
-diyl)-β-D-arabinofuranosyl]adenine and the starting material 3',5'-O-(tetraisopropyldisiloxane-1,3-diyl)adenosine are produced; It has been found that since no other by-products are involved, there is no need for complicated purification using ion exchange resins or other special purification means, and based on this knowledge, the present invention has been accomplished.
すなわち、本発明は、
(イ) 3′,5′―O―(テトライソプロピルジシロキ
サン―1,3―ジイル)アデノシンをジメチル
スルホキシド及び無水酢酸で処理して対応する
2′―ケト体に変換する工程、
(ロ) (イ)工程で得た2′―ケト体を還元処理する工
程、
(ハ) (ロ)工程の反応混合物から9―〔3′,5′―O―
(テトライソプロピルジシロキサン―1,3―
ジイル)―β―D―アラビノフラノシル〕アデ
ニンと3′,5′―O―(テトライソプロピルジシ
ロキサン―1,3―ジイル)アデノシンとを分
離し、後者を(イ)工程へ循環させる工程及び
(ニ) (ハ)工程で分離された9―〔3′,5′―O―(テ
トライソプロピルジシロキサン―1,3―ジイ
ル)―β―D―アラビノフラノシル〕アデニン
から保護基を脱離させることにより9―(β―
D―アラビノフラノシル)アデニンを得る工程
から成ることを特徴とする9―(β―D―アラビ
ノフラノシル)アデニンの製造方法を提供するも
のである。 That is, the present invention provides a method for treating (a) 3',5'-O-(tetraisopropyldisiloxane-1,3-diyl)adenosine with dimethyl sulfoxide and acetic anhydride.
(b) a step of reducing the 2'-keto form obtained in step (b); (c) converting the reaction mixture of step (b) into 9-[3',5' -O-
(Tetraisopropyldisiloxane-1,3-
A step of separating diyl)-β-D-arabinofuranosyl]adenine and 3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)adenosine and recycling the latter to step (a). and (d) removing the protecting group from the 9-[3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)-β-D-arabinofuranosyl]adenine separated in step (c). By desorption, 9-(β-
The present invention provides a method for producing 9-(β-D-arabinofuranosyl)adenine, which comprises a step of obtaining D-arabinofuranosyl)adenine.
本発明方法において、出発原料として用いる
3′,5′―O―(テトライソプロピルジシロキサン
―1,3―ジイル)アデノシンは、容易に入手で
きる安価なアデノシンに、1,3―ジクロル―
1,1,3,3―テトライソプロピルジシロキサ
ンを反応させることにより定量的収率で得られる
化合物であり、このものはなんら精製処理を施す
ことなくそのまま後続工程に供すことができるの
で工業的に実施する方法の出発原料としては好適
なものである。 Used as a starting material in the method of the present invention
3',5'-O-(tetraisopropyldisiloxane-1,3-diyl)adenosine is a readily available and inexpensive adenosine with 1,3-dichloro-
It is a compound obtained in quantitative yield by reacting 1,1,3,3-tetraisopropyldisiloxane, and this compound can be used in the subsequent process as it is without any purification treatment, so it is industrially suitable. It is suitable as a starting material for the method carried out.
本発明方法の(イ)工程は、前記の3′,5′―O―
(テトライソプロピルジシロキサン―1,3―ジ
イル)アデノシンを、室温下で8〜12倍量のジメ
チルスルホキシドに溶解し、次いでこれに原料の
4〜6倍量の無水酢酸を加え、暫時かきまぜたの
ち、5〜20時間放置することによつて行われる。 Step (a) of the method of the present invention is the above-mentioned 3',5'-O-
(Tetraisopropyldisiloxane-1,3-diyl)adenosine was dissolved in 8 to 12 times the amount of dimethyl sulfoxide at room temperature, then 4 to 6 times the amount of acetic acid as the raw material was added thereto, and after stirring for a while. , by leaving it for 5 to 20 hours.
次にこれを加水分解し、適当な溶媒例えば酢酸
エチルで抽出し、洗浄後溶媒を留去することによ
り、高純度の対応するケト体が得られる。 Next, this is hydrolyzed, extracted with a suitable solvent such as ethyl acetate, and after washing, the solvent is distilled off to obtain a highly pure corresponding keto compound.
このように(イ)工程は、以下の反応式に従つて進
行する。 In this way, step (a) proceeds according to the following reaction formula.
(式中のRはイソプロピル基)
次に本発明方法の(ロ)工程は、(イ)工程で得た2′―
ケト体を、適当な溶媒例えばベンゼン―エタノー
ル混液中に溶解し、慣用の還元剤例えば水素化ホ
ウ素ナトリウム2〜3倍モルを加え、冷却しなが
ら反応させることにより行われる。この処理によ
り2′位のケト基が還元されて水酸基となるが、こ
の際、意外にも2′―水酸基が3′―置換基に対して
トランス型配置をとるアラビノフラノシル体が圧
倒的に多く生成し、シス型配置のものの生成量は
少ない。 (R in the formula is an isopropyl group) Next, in step (b) of the method of the present invention, the 2′-
The reaction is carried out by dissolving the keto compound in a suitable solvent such as a benzene-ethanol mixture, adding a conventional reducing agent such as 2 to 3 times the mole of sodium borohydride, and reacting with cooling. Through this treatment, the keto group at the 2'-position is reduced to a hydroxyl group, but surprisingly, the arabinofuranosyl form in which the 2'-hydroxyl group takes a trans configuration with respect to the 3'-substituent is overwhelmingly produced. A large amount is produced in the cis-configuration, and a small amount is produced in the cis-configuration.
この(ロ)工程は、以下の反応式に従つて進行す
る。 This step (b) proceeds according to the following reaction formula.
(式中のRは前記と同じ)
本発明方法の(ハ)工程においては、上記のように
して得たトランス型のものすなわち9―〔3′,
5′―O―(テトライソプロピルジシロキサン―
1,3―ジイル)―β―D―アラビノフラノシ
ル〕アデニンとシス型のものすなわち3′,5′―O
―(テトライソプロピルジシロキサン―1,3―
ジイル)アデノシンとを分離し、後者を(イ)工程に
循環させ再使用するのであるが、この分離は例え
ばシリカゲル又はアルミナを用いたクロマトグラ
フイーにより容易に行うことができる。この工程
で分離される9―〔3′,5′―O―(テトライソプ
ロピルジシロキサン―1,3―ジイル)―β―D
―アラビノフラノシル〕アデニンは文献未載の新
規化合物で、通常無晶形で得られる。 (R in the formula is the same as above) In step (c) of the method of the present invention, the trans type obtained as above, that is, 9-[3',
5′-O-(tetraisopropyldisiloxane-
1,3-diyl)-β-D-arabinofuranosyl]adenine and the cis form, i.e. 3′,5′-O
-(Tetraisopropyldisiloxane-1,3-
(diyl)adenosine and the latter is recycled to step (a) for reuse. This separation can be easily performed, for example, by chromatography using silica gel or alumina. 9-[3',5'-O-(tetraisopropyldisiloxane-1,3-diyl)-β-D separated in this step
-arabinofuranosyl]adenine is a new compound that has not been described in the literature and is usually obtained in an amorphous form.
このものは、他の共存物質からの分離が容易で
あり、しかも保護基の脱離及び脱離後の生成物の
精製が容易であるという特徴を有している。 This product has the characteristics that it can be easily separated from other coexisting substances, and that it is easy to remove the protecting group and purify the product after the removal.
本発明方法の(ニ)工程においては前工程で分離さ
れた9―〔3′,5′―O―テトライソプロピルジシ
ロキサン―1,3―ジイル)―β―D―アラビノ
フラノシル〕アデニンを例えばテトラヒドロフラ
ンのような溶媒に溶解し、これにテトラブチルア
ンモニウムフルオライトを加えて反応させること
により保護基を脱離させる。このようにして得ら
れる目的物のアラビノフラノシルアデニンは、な
んらイオン交換クロマトグラフイーなど特殊な精
製手段を用いることなく、単に含水メタノールを
加えて結晶化させるだけで、ほとんど定量的に回
収される。 In step (2) of the method of the present invention, the 9-[3',5'-O-tetraisopropyldisiloxane-1,3-diyl)-β-D-arabinofuranosyl]adenine separated in the previous step is For example, the protecting group is removed by dissolving in a solvent such as tetrahydrofuran and adding tetrabutylammonium fluorite to the solution for reaction. The target arabinofuranosyladenine obtained in this way can be recovered almost quantitatively by simply adding water-containing methanol and crystallizing it, without using any special purification means such as ion exchange chromatography. Ru.
このようにして得られたアラビノフラノシルア
ラニンの赤外線吸収スペクトル、紫外部吸収スペ
クトルは、標品のそれと完全に一致した。 The infrared absorption spectrum and ultraviolet absorption spectrum of the arabinofuranosylalanine thus obtained completely matched those of the standard product.
この(ニ)工程は、以下の反応式に従つて進行す
る。 This (d) step proceeds according to the following reaction formula.
本発明方法は、入手の容易なアデノシンから簡
単に製造される3′,5′―O―(テトライソプロピ
ルジシロキサン―1,3―ジイル)アデノシンを
出発原料とし、少数の工程で、高収率かつ高純度
で目的物たるアラビノフラノシルアデニンを得る
ことができる上に、製造過程中で生じる唯一の副
生物である3′,5′―O―(テトライソプロピルジ
シロキサン―1,3―ジイル)アデノシンはその
まま出発原料として循環再使用しうるので、工業
的方法として好適である。 The method of the present invention uses 3',5'-O-(tetraisopropyldisiloxane-1,3-diyl)adenosine, which is easily produced from readily available adenosine, as a starting material, and produces high yields in a small number of steps. In addition to being able to obtain the target arabinofuranosyladenine with high purity, the only by-product produced during the manufacturing process is 3',5'-O-(tetraisopropyldisiloxane-1,3-diyl). ) Since adenosine can be recycled and reused as it is as a starting material, it is suitable as an industrial method.
次に実施例により本発明をさらに詳細に説明す
る。 Next, the present invention will be explained in more detail with reference to Examples.
参考例
3′,5′―O―(テトライソプロピルジシロキサ
ン―1,3―ジイル)アデノシンの製造
アデノシン8.0g(30mmole)をピリジン150ml
に懸濁し、室温でかきまぜながら、1,3―ジク
ロル―1,1,3,3―テトライソプロピルジシ
ロキサン10.4g(33mmole)とピリジン15mlとの
混液を10分間で滴下した。次いで1時間かきま
ぜ、ジメチルホルミアミド15mlを添加してさらに
1時間かきまぜると反応混合物は溶液となつた。
次に反応液を減圧下留去し、得られた残渣に酢酸
エチル300mlを加えて溶解し、炭酸水素ナトリウ
ム水溶液、次いで水で洗浄し、無水硫酸マグネシ
ウムで脱水処理後、減圧下に溶剤を留去し、無晶
形の表題化合物15.3gを得た。粗収率100.3%本
品は精製することなく次の工程に使用することが
できる。Reference example 3',5'-O-(tetraisopropyldisiloxane-1,3-diyl)adenosine production 8.0g (30mmole) of adenosine was mixed with 150ml of pyridine.
A mixed solution of 10.4 g (33 mmole) of 1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane and 15 ml of pyridine was added dropwise over 10 minutes while stirring at room temperature. After stirring for 1 hour, 15 ml of dimethylformamide was added and the mixture was stirred for an additional hour until the reaction mixture became a solution.
Next, the reaction solution was distilled off under reduced pressure, and the resulting residue was dissolved in 300 ml of ethyl acetate, washed with an aqueous sodium bicarbonate solution and then with water, dehydrated with anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. 15.3 g of the amorphous title compound was obtained. Crude yield: 100.3% This product can be used in the next step without purification.
実施例 1
参考例で得られた3′,5′―O―(テトライソプ
ロピルジシロキサン―1,3―ジイル)アデノシ
ン5.1g(10mmole)をジメチルスルホキシド60
mlに溶解し、これに無水酢酸30mlを加え、一夜か
きまぜて十分反応させた。得られた反応混合物を
氷200g中に加え、2時間かきまぜたのち、酢酸
エチル300mlで2回抽出し、抽出有機層を炭酸水
素ナトリウム水溶液、次いで水でそれぞれ数回洗
浄し、無水硫酸マグネシウムを加えて脱水乾燥し
た。次に減圧下に溶剤を留去し、得られたシロツ
プをベンゼン―エタノール(1:1v/v)混液
150mlに溶解し、0℃に冷却したのち、水素化ホ
ウ素ナトリウム1g(26mmole)を加え、2時
間同温度に保つてかきまぜた。これにアセトン10
mlを加え、さらに30分間かきまぜたのち、反応液
を減圧留去し、残留物を水100mlに溶解した。次
いで10%塩酸を加えてPHを2に調整したのち、酢
酸エチル200mlで2回抽出し、抽出有機層を食塩
水、次いで水でそれぞれ数回洗浄し、無水硫酸マ
グネシウムで乾燥した。これを減圧下に溶媒を留
去して得られたシロツプをシリカゲルを充てんし
たカラムを用い、クロロホルム―メタノール
(95:5v/v)1.2で展開し、最初に溶出した
0.8を第一分画とし、その後の0.4を第二分画
として別々の受器に採取した。この各分画から、
それぞれ溶媒を留去することにより第一分画から
3′,5′―O―(テトライソプロピルジシロキサン
―1,3―ジイル)アデノシン1.2gを、また第
二分画から無晶形の9―〔3′,5′―O―(テトラ
イソプロピルジシロキサン―1,3―ジイル)―
β―O―アラビノフラノシル〕アデニン2.9g
(収率74.0%)を得た。Example 1 5.1 g (10 mmole) of 3',5'-O-(tetraisopropyldisiloxane-1,3-diyl)adenosine obtained in Reference Example was mixed with 60 g of dimethyl sulfoxide.
ml, 30 ml of acetic anhydride was added thereto, and the mixture was stirred overnight to allow sufficient reaction. The resulting reaction mixture was added to 200 g of ice, stirred for 2 hours, extracted twice with 300 ml of ethyl acetate, the extracted organic layer was washed several times with an aqueous sodium bicarbonate solution and then with water, and anhydrous magnesium sulfate was added. It was dehydrated and dried. Next, the solvent was distilled off under reduced pressure, and the resulting syrup was mixed with a benzene-ethanol (1:1 v/v) mixture.
After dissolving in 150 ml and cooling to 0°C, 1 g (26 mmole) of sodium borohydride was added, and the mixture was kept at the same temperature for 2 hours with stirring. This and acetone 10
After stirring for an additional 30 minutes, the reaction solution was distilled off under reduced pressure, and the residue was dissolved in 100 ml of water. Next, 10% hydrochloric acid was added to adjust the pH to 2, followed by extraction twice with 200 ml of ethyl acetate, and the extracted organic layer was washed several times with brine and then with water, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the resulting syrup was developed with chloroform-methanol (95:5 v/v) 1.2 using a column filled with silica gel, and the first elution was carried out.
0.8 was taken as the first fraction, and the subsequent 0.4 was collected as the second fraction into separate receivers. From each fraction,
from the first fraction by distilling off the solvent, respectively.
1.2 g of 3',5'-O-(tetraisopropyldisiloxane-1,3-diyl)adenosine and amorphous 9-[3',5'-O-(tetraisopropyldisiloxane) from the second fraction. -1,3-diyl)-
β-O-arabinofuranosyl]adenine 2.9g
(yield 74.0%).
3′,5′―O―(テトライソプロピルジシロキサ
ン―1,3―ジイル)アデノシンを、参考例に従
つて新たに製造された原料と混合して再使用した
が、なんらの支障も認められなかつた。 3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)adenosine was reused by mixing it with newly produced raw materials according to the reference example, but no problems were observed. Ta.
次に、前記のようにして得た無晶形の9―
〔3′,5′―O―(テトライソプロピルジシロキサ
ン―1,3―ジイル)―β―D―アラビノフラノ
シル〕アデニン2.9gをテトラヒドロフラン14.5
mlにに溶解し、これにテトラブチルアンモニウム
フルオライドのテトラヒドロフラン溶液(1M)
14.5mlを加え、室温で10分間かきまぜたのち、水
5mlを加え、反応液を減圧下に留去した。ここで
得られたシロツプを水12mlとメタノール60mlの混
液に溶解し、種晶して室温で一夜静置した。 Next, the amorphous 9-
2.9 g of [3',5'-O-(tetraisopropyldisiloxane-1,3-diyl)-β-D-arabinofuranosyl]adenine and 14.5 g of tetrahydrofuran
A solution of tetrabutylammonium fluoride in tetrahydrofuran (1M) is dissolved in this.
After adding 14.5 ml and stirring at room temperature for 10 minutes, 5 ml of water was added and the reaction solution was distilled off under reduced pressure. The syrup obtained here was dissolved in a mixed solution of 12 ml of water and 60 ml of methanol, seeded, and allowed to stand overnight at room temperature.
析出した結晶をろ取し、少量のメタノールで洗
浄したのち乾燥し、9―(β―D―アラビノフラ
ノシル)アデニンの結晶1.45gを得た収率95.4
%、融点255〜257゜、λnax(EtOH)258.5nm
(ε13800)、また、本品についての赤外線吸収スペ
クトル、薄層クロマトグラフイーの測定結果は標
品のそれらと完全に一致した。 The precipitated crystals were collected by filtration, washed with a small amount of methanol, and then dried to obtain 1.45 g of crystals of 9-(β-D-arabinofuranosyl) adenine, yield 95.4.
%, melting point 255-257゜, λ nax (EtOH) 258.5nm
(ε13800), and the infrared absorption spectrum and thin layer chromatography measurement results for this product completely matched those of the standard product.
Claims (1)
ロキサン―1,3―ジイル)アデノシンをジメ
チルスルホキシド及び無水酢酸で処理して対応
する2′―ケト体に変換する工程、 (ロ) (イ)工程で得た2′―ケト体を還元処理する工
程、 (ハ) (ロ)工程の反応混合物から9―〔3′,5′―O―
(テトライソプロピルジシロキサン―1,3―
ジイル)―β―D―アラビノフラノシル〕アデ
ニンと3′,5′―O―(テトライソプロピルジシ
ロキサン―1,3―ジイル)アデノシンとを分
離し、後者を(イ)工程へ循環させる工程及び (ニ) (ハ)工程で分離された9―〔3′,5′―O―(テ
トライソプロピルジシロキサン―1,3―ジイ
ル)―β―D―アラビノフラノシル〕アデニン
から保護基を脱離させることにより9―(β―
D―アラビノフラノシル)アデニンを得る工程 から成ることを特徴とする9―(β―D―アラビ
ノフラノシル)アデニンの製造方法。[Scope of Claims] 1 (a) 3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)adenosine is converted to the corresponding 2′-keto form by treating with dimethyl sulfoxide and acetic anhydride. (b) A step of reducing the 2'-keto form obtained in step (a), (c) Reducing 9-[3',5'-O- from the reaction mixture of step (b)
(Tetraisopropyldisiloxane-1,3-
A step of separating diyl)-β-D-arabinofuranosyl]adenine and 3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)adenosine and recycling the latter to step (a). and (d) removing the protecting group from the 9-[3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)-β-D-arabinofuranosyl]adenine separated in step (c). By desorption, 9-(β-
A method for producing 9-(β-D-arabinofuranosyl)adenine, which comprises a step of obtaining D-arabinofuranosyl)adenine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57123913A JPS5913800A (en) | 1982-07-16 | 1982-07-16 | Preparation of 9-(beta-d-arabinofuranosyl)adenine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57123913A JPS5913800A (en) | 1982-07-16 | 1982-07-16 | Preparation of 9-(beta-d-arabinofuranosyl)adenine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5913800A JPS5913800A (en) | 1984-01-24 |
| JPS635040B2 true JPS635040B2 (en) | 1988-02-01 |
Family
ID=14872439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57123913A Granted JPS5913800A (en) | 1982-07-16 | 1982-07-16 | Preparation of 9-(beta-d-arabinofuranosyl)adenine |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5913800A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0921140A (en) * | 1995-07-07 | 1997-01-21 | Minoru Tomita | Lightweight sheathing panel method |
-
1982
- 1982-07-16 JP JP57123913A patent/JPS5913800A/en active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0921140A (en) * | 1995-07-07 | 1997-01-21 | Minoru Tomita | Lightweight sheathing panel method |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5913800A (en) | 1984-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3653292B2 (en) | Mass production of 2 ', 3'-didehydro-3'-deoxythymidine (d4T) using 5-methyluridine | |
| CA1135258A (en) | Process for the preparation of 5'deoxy-5-fluorouridine | |
| JP2005504036A (en) | Method for preparing purine nucleosides | |
| US5466793A (en) | Process for preparing 2', 3'- dideoxyinosine | |
| JPH0797391A (en) | Nucleoside derivative and its production | |
| JPS635040B2 (en) | ||
| EP0653437B1 (en) | Process for preparing AZT and derivatives thereof | |
| US5290927A (en) | Process for preparing 2',3'-dideoxyadenosine | |
| JPH06135988A (en) | Nucleotide derivative | |
| JPH058200B2 (en) | ||
| JPH0217199A (en) | Production of 2'-deoxy-beta-adenosine | |
| CN1184228C (en) | Process for the preparation of a deoxyuridine derivative | |
| US8338586B2 (en) | Process of making cladribine | |
| JP3128080B2 (en) | Novel method for producing nucleic acid compounds | |
| WO2020256084A1 (en) | Crosslinked nucleoside intermediate crystal and method for producing same, and method for producing crosslinked nucleoside amidite | |
| JP3123238B2 (en) | Purification method of nucleoside derivative | |
| JPH07165785A (en) | Process for producing 3'-fluoropyrimidine nucleosides | |
| JP2701114B2 (en) | Method for producing 3'-amino-2'-hydroxyacetophenone | |
| IL117225A (en) | Preparation of d4t from 5-methyluridine and some novel intermediates thereof | |
| JP2770357B2 (en) | Method for producing nucleoside derivative | |
| EP1397373B1 (en) | Improved synthesis of allofuranose | |
| DK170051B1 (en) | 14-Chlordaunomycin and acid addition salts thereof, process for the preparation of (2 "R) -4'-O-tetrahydropyranyladriamycin and (2" R) -14-chloro-4'-O-tetrahydropyranyldunomycin | |
| JPH01224390A (en) | Production of nucleoside derivative | |
| JP3023804B2 (en) | Method for producing 3'-deoxy-3'-fluorothymidine | |
| JP3070863B2 (en) | Method for producing 2 ', 3'-dideoxypyrimidine nucleosides |